Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model

ASCO 2024

Head and Neck Cancer

HPV vaccine can reduce the risk of HPV-related head and neck cancers in men

Head and Neck Cancer

Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Lancet Oncol

Abou-Foul AK, Henson C, Chernock RD, Huang SH, Lydiatt WM, McDowell L, O'Sullivan B, Perez-Ordonez B, Robinson M, Nankivell PC, Ruiz-Bravo E, Chiosea SI, Green TM, Hunter KD, Hwang JS, Koljenovic S, Koppes SA, Larsen SR, Lo AWI, Costes-Martineau V, Mittal N, Mori T, Nagao T, Panayiotides IG, Pinto CAL, Scheckenbach K, Seethala RR, Ulhøi BP, Vingiani A, Zhang Y, Yom SS, Mehanna H

doi: 10.1016/S1470-2045(24)00143-8

Head and Neck Cancer

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

J Clin Oncol

Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tân PF, Siu LL, Holsinger FC, El-Naggar A, Chung C, Cmelak A, Burtness B, Bednarz G, Quon H, Breen SL, Gwede CK, Dicker AP, Yao M, Jordan RC, Dorth J, Lee N, Chan JW, Dunlap N, Bar-Ad V, Stokes WA, Chakravarti A, Sher D, Rao S, Harris J, Yom SS, Le QT, NRG Oncology RTOG 0920 Collaborating Team, TransSCOT Consortium

doi: 10.1200/JCO-24-01829

Head and Neck Cancer

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations

Lancet Oncol

Lim AM, Le Tourneau C, Hurt C, Laskar SG, Steuer CE, Chow VLY, Szturz P, Henson C, Day AT, Bates JE, Lazarakis S, McDowell L, Mehanna H, Yom SS, HNCIG

doi: 10.1016/S1470-2045(24)00068-8

Genitourinary Cancer

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI-Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk-Stratification Scoring System

Prostate

Takahashi T, Nakashima M, Maruno K, Hazama T, Yamada Y, Kikkawa K, Umeoka S, Tamaki M, Ito N

doi: 10.1002/pros.24821

Head and Neck Cancer

Chronotherapy in head and neck cancer: A systematic review and meta-analysis

Int J Cancer

Abusamak M, Abu-Samak AA, Cai W, Al-Waeli H, Al-Hamed FS, Al-Tamimi M, Juweid M, Chaurasia A, Nicolau B, Tamimi F

doi: 10.1002/ijc.35234

Lymphoma

Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study

Am J Hematol

Ma S, La J, Swinnerton KN, Guffey D, Bandyo R, De Las Pozas G, Hanzelka K, Xiao X, Rojas-Hernandez CM, Amos CI, Chitalia V, Ravid K, Merriman KW, Flowers CR, Fillmore N, Li A

doi: 10.1002/ajh.27335

Gastrointestinal Cancer

Panacreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study

Eur J Cancer

Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L

doi: 10.1016/j.ejca.2024.115140

ASCO 2024

Gynecologic Cancer

Related content

HPV vaccine can reduce the risk of HPV-related head and neck cancers in men

Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI-Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk-Stratification Scoring System

Chronotherapy in head and neck cancer: A systematic review and meta-analysis

Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study

Panacreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study

Estrogen-only hormone therapy may increase ovarian cancer risk, while estrogen-progestin combination may lower the risk of endometrial cancer